Clinical Trial Update: Efficacy and Safety of Sirolimus in Children and Adolescents With Juvenile Nasopharyngeal Angiofibroma (JNA) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of sirolimus in children and adolescents with Juvenile Nasopharyngeal Angiofibroma and is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Nasopharyngeal Angiofibroma

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Conditions: Juvenile Nasopharyngeal Angiofibroma | Phase 3 | Status: RECRUITING